A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Coherent Biopharma (Hefei) Co., Ltd.
University of Milano Bicocca
Lebanese University
Kineta Inc.
Université Sorbonne Paris Nord
Provectus Pharmaceuticals
Blue Note Therapeutics
Assistance Publique - Hôpitaux de Paris
Weprom
TScan Therapeutics, Inc.
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
SpeciCare
Petra Pharma
Xuanwu Hospital, Beijing
Optimata Ltd.
SPGO Research Mannheim GmbH
The Cooper Health System
Tianjin Medical University Cancer Institute and Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Center, Korea